🇺🇸 FDA

Intelligence · Clinical Pipeline

Metabolic & obesity R&D Pipeline

GLP-1, metabolic disease, obesity, and diabetes pipeline programs with sponsor and trial ID cross-links.

Programs
755

Quick answer

Metabolic & obesity: NovaPharmaNews indexes 755 metabolic & obesity clinical pipeline programs from ClinicalTrials.gov with phase, modality, NCT identifiers, and sponsor company links. GLP-1, metabolic disease, obesity, and diabetes pipeline programs with sponsor and trial ID cross-links.

Top sponsors

Page 15 of 16

  1. Semaglutide

    United Therapeutics Europe Ltd

    Obesity

    approved small molecule terminated

    1 trial

  2. Semaglutide B 3.0 mg/ml PDS290

    Disc Medicine

    obesity

    approved small molecule active

    1 trial

  3. Sham Injection

    HALOZYME THERAPEUTICS, INC.

    Type 1 Diabetes Mellitus

    approved small molecule completed

    1 trial

  4. Simvastatin

    Hospital Authority, Hong Kong

    Obesity

    approved small molecule active

    1 trial

  5. Sitagliptin

    Chen Suning

    Type 2 Diabetes

    approved small molecule completed

    1 trial

  6. Sitagliptin 50mg Film-coated Tablets, Trajenta 5 mg film-coated tablets, Pioglitazone Mylan 15 mg compresse, Ozempic 0.5 mg solution for injection in pre-filled pen, Jardiance 10 mg film-coated tablets, GLUCOPHAGE 1000 mg potahované tablety, Invokana 100 mg film-coated tablets, Trulicity 1.5 mg solution for injection in pre-filled pen, Galvus 50 mg tablets, Forxiga 10 mg film-coated tablets

    The George Institute

    Type 2 Diabetes Mellitus

    approved small molecule active

    1 trial

  7. Subcutaneous glargine insulin

    Lxo Ireland Designated Activity Company

    Diabetes Mellitus

    approved small molecule completed

    1 trial

  8. Sulfato de Magnesio Altan 150 mg/ml solución inyectable y para perfusión EFG, LIDOCAINE HYDROCHLORIDE, Dexdor 100 micrograms/ml concentrate for solution for infusion, KETOLAR 50 mg/ml solución inyectable.

    The George Institute

    Obesity

    approved small molecule active

    1 trial

  9. Tirzepatide

    The First People's Hospital of Lianyungang

    Type 2 Diabetes Mellitus

    approved small molecule active

    1 trial

  10. Toujeo

    Almirall, S.A.

    Diabetes Mellitus, Type 2

    approved small molecule completed

    1 trial

  11. Trelagliptin

    Takeda

    Type 2 Diabetes

    approved small molecule completed

    1 trial

  12. Trelagliptin

    Takeda

    Type 2 Diabetes Mellitus

    approved small molecule completed

    2 trials

  13. Triple combination therapy group

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Type 2 Diabetes Mellitus

    approved small molecule completed

    1 trial

  14. Vortioxetine

    Takeda

    Type2 Diabetes

    approved small molecule terminated

    1 trial

  15. Wegovy 0.25 mg FlexTouch solution for injection in pre-filled pen, Wegovy 1 mg FlexTouch solution for injection in pre-filled pen, Wegovy 0.5 mg FlexTouch solution for injection in pre-filled pen, Wegovy 2.4 mg FlexTouch solution for injection in pre-filled pen, Wegovy 1.7 mg FlexTouch solution for injection in pre-filled pen

    NovoThirteen

    Obesity

    approved small molecule active

    1 trial

  16. aflibercept 2.0 mg

    Regeneron UK Limited

    Diabetic Macular Edema

    approved small molecule completed

    1 trial

  17. alogliptin+pioglitazone

    Takeda

    Diabetes Mellitus, Type 2

    approved small molecule terminated

    1 trial

  18. biphasic insulin aspart 30

    Novo Nordisk A/S

    Diabetes

    approved small molecule completed

    2 trials

  19. cagrilintide, Placebo + Placebo, semaglutide, cagrilintide, cagrilintide semaglutide, semaglutide, semaglutide, semaglutide, cagrilintide semaglutide, semaglutide, cagrilintide semaglutide, cagrilintide semaglutide, cagrilintide semaglutide, cagrilintide, cagrilintide

    NovoThirteen

    Obesity and T2D

    approved small molecule active

    1 trial

  20. dapagliflozin

    The First People's Hospital of Lianyungang

    Diabetic Kidney Disease

    approved small molecule active

    1 trial

  21. glargine + exenatide

    Hong Kong Baptist University

    Type 2 Diabetes Mellitus

    approved small molecule completed

    1 trial

  22. insulin detemir

    Novo Nordisk A/S

    Diabetes

    approved small molecule completed

    2 trials

  23. insulin lispro injection, exenatide injection

    The First People's Hospital of Lianyungang

    Diabetes Mellitus, Type 2

    approved small molecule completed

    1 trial

  24. metformin

    Boehringer Ingelheim

    Diabetes Mellitus, Type 2

    approved small molecule completed

    1 trial

  25. pioglitazone

    Takeda

    Type 2 Diabetes Mellitus

    approved small molecule completed

    4 trials

  26. pioglitazone

    Takeda

    Type 2 Diabetes

    approved small molecule completed

    1 trial

  27. pioglitazone

    GlaxoSmithKline

    Diabetes Mellitus, Type 2

    approved small molecule terminated

    1 trial

  28. pregabalin

    Pfizer

    Diabetic Neuropathy, Painful

    approved small molecule completed

    1 trial

  29. premeal insulin lispro mixtures

    Eli Lilly and Company

    Diabetes Mellitus, Type 2

    approved small molecule completed

    1 trial

  30. 25% Carbohydrate solution (CHO drinking)

    Hospital Authority, Hong Kong

    Type2diabetes

    other completed

    1 trial

  31. Cambridge Weight Plan

    United Therapeutics Europe Ltd

    Diabetes

    other active

    1 trial

  32. Canagliflozin

    The First People's Hospital of Lianyungang

    Type 2 Diabetes Mellitus With Complication

    small molecule active

    1 trial

  33. DPP4

    The First People's Hospital of Lianyungang

    Type 2 Diabetes Mellitus

    small molecule active

    1 trial

  34. Dapagliflozin

    Hospital Authority, Hong Kong

    Diabetes Mellitus, Type 2

    small molecule completed

    1 trial

  35. Dietary intervention + Physical Activity + Monitoring

    NORTHWEST BIOTHERAPEUTICS INC

    Gestational Diabetes

    other active

    1 trial

  36. Duragtide, Semaglutide, losenatide, tirzepatide, ebenatide, etc

    The First People's Hospital of Lianyungang

    Diabetes

    small molecule active

    1 trial

  37. EPCs plus PTA

    The First People's Hospital of Lianyungang

    Diabetic Foot

    mab active

    1 trial

  38. Early auto-mode

    Century Therapeutics

    Diabetes Mellitus Type 1 Pre-Existing

    other completed

    1 trial

  39. Experimental group

    The First People's Hospital of Lianyungang

    Overweight or Obesity

    other active

    1 trial

  40. Fecal Microbiota Transplantation (FMT)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Type 1 Diabetes

    mab active

    1 trial

  41. Fosinopril

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Diabetes Mellitus

    small molecule completed

    1 trial

  42. Fresh organic vegetables

    United Therapeutics Europe Ltd

    Diabetes Mellitus, Type 2

    other terminated

    1 trial

  43. GLP-1 Receptor Agonists

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Short Bowel Syndrome (SBS)

    small molecule active

    1 trial

  44. Genetic testing for 4 MODY genes (GCK, HNF1A, HNF4A, HNF1B)

    United Therapeutics Europe Ltd

    Maturity-onset Diabetes of the Young

    other active

    1 trial

  45. Glimepiride

    Takeda

    Type 2 Diabetes

    small molecule active

    1 trial

  46. High Dose GGQL Decoction

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Diabetes Mellitus, Type 2

    small molecule active

    1 trial

  47. Huangqi Guizhi Wuwu decoction

    The First People's Hospital of Lianyungang

    Diabetic Nephropathies

    small molecule active

    1 trial

  48. Insulin

    The First People's Hospital of Lianyungang

    Gestational Diabetes

    small molecule active

    1 trial

Frequently asked questions

How many metabolic & obesity pipeline programs are tracked?

755 programs match this therapeutic area based on indication text, program name, and registry metadata.

Where does pipeline data come from?

ClinicalTrials.gov records linked to NovaPharmaNews company profiles. Verify on ClinicalTrials.gov before investment decisions.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.